EDGAR Filing Documents for 0001485003-17-000088

Form S-1 - General form for registration of securities under the Securities Act of 1933:

SEC Accession No. 0001485003-17-000088

Filing Date

2017-10-04

Accepted

2017-10-04 17:08:13

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-1	ebioforms-12017xshortform.htm	S-1	490627
2	EXHIBIT 5.1	ex51opinionhogan.htm	EX-5.1	10577
3	EXHIBIT 23.1	ex231consentofey.htm	EX-23.1	2364
4	EXHIBIT 23.2	ex232consentofpwc.htm	EX-23.2	2773
5		ebiologoa27.jpg	GRAPHIC	3986
6		ebiologoa28.jpg	GRAPHIC	89522
7		hllogo.jpg	GRAPHIC	28096
	Complete submission text file	0001485003-17-000088.txt		674743

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142

Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550

Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-220809 | Film No.: 171122399
SIC: 2834 Pharmaceutical Preparations